Company: GVH
Filing Date: 2025-06-27
Form Type: 424B4
Source: 0001213900-25-058674
Chunk: 38

Company: Globavend Holdings Ltd
Filing Date: 2025-06-27
Form: 424B4
Chunk 38
---
 or recommended solely by independent directors. |

As a result, you will not have the same protection afforded to shareholders of companies that are subject to these corporate governance requirements. Although we do not intend to rely on the “controlled company” exemption under the Nasdaq listing rules, we could elect to rely on this exemption. If we elected to rely on the “controlled company” exemption, a majority of the members of our board of directors might not be independent directors and our nominating and corporate governance and compensation committees might not consist entirely of independent directors. See “ Risk Factors — Risks Related to Our Ordinary Shares and This Offering — As a “controlled company” under the rules of Nasdaq, we may choose to exempt our Company from certain corporate governance requirements that could have an adverse effect on our public shareholders.” Implications of Being an Emerging Growth Company and a Foreign Private Issuer As a company with less than US$1.235 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”), enacted in April 2012, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. These provisions include, but are not limited to:

| ● | being permitted to present only two years of audited                                                                       
 financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results 
 of Operations in our filings with the SEC;                                                                                 |

| ● | not being required to comply with the auditor attestation                        
 requirements in the assessment of our internal control over financial reporting; |

| ● | reduced disclosure obligations regarding executive compensation         
 in periodic reports, proxy statements, and registration statements; and |

| ● | exemptions from the requirements of holding a nonbinding                                                                   
 advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. |

We may take advantage of these provisions until the last day of our fiscal year following the fifth anniversary of the date of the first sale of our Ordinary Shares pursuant to our IPO in November 2023. However, if certain events occur before the end of such five-year period, including if we become a “large accelerated filer,” our annual gross revenues exceed US$1.235 billion, or we issue more than US$1 billion of non-convertible debt in any three-year period, we will cease to be an emerging growth company before the end of such five-year period.

<div align='center'>9</div>

In addition,